© Provided by Daily MailMailOnline logo
COVID-19 vaccines made by Pfizer and Moderna reduce the risk of getting sick from the virus by 94 percent, according to real-world data form the largest Centers for Disease Control and Prevention (CDC) study to-date.
Only six percent of COVID-19 cases among more than 1,800 health care workers were in people fully-vaccinated with one of the two mRNA shots, according to the new study, released Friday. No one included in the study had had the Johnson & Johnson vaccine.
The study was only designed to test whether the vaccines prevented people from getting symptomatic COVID-19, but the fact that only a small fraction of the group who tested positive were fully vaccinated suggests that the shots likely prevent infection and transmission - not just illness.
'This report provided the most compelling information to date that COVID-19 vaccines were performing as expected in the real world,' said CDC Director Dr Rochelle Walensky in a statement accompanying the new study.
'This study, added to the many studies that preceded it, was pivotal to CDC changing its recommendations for those who are fully vaccinated against COVID-19.'
It was among the pieces of evidence that the CDC drew upon in updating its guidance for fully vaccinated Americans to say that those who have had all their Covid shots can safely go without masks outdoors or indoors, with a few exceptions including crowded places like planes and buses.
© Provided by Daily MailOnly six percent of COVID-19 cases among more than 1,800 health care workers were in people fully-vaccinated with one of the two mRNA shots, according to the new CDC study
© Provided by Daily Mail The study drew upon a network of more than 500,000 health care workers.
Its data was whittled down to 1,843 participating nurses, doctors and hospital staff, all of whom were likely exposed to COVID-19 on the job.
Among the group, there were a total 623 people who had tested positive for COVID-19 and had at least one symptom of the infection, and 1,220 people who tested negative.
Only 40 out of the 623 people who tested positive had been fully vaccinated.
Video: Major screening for ovarian cancer did not prevent early deaths (Cover Video)
Major screening for ovarian cancer did not prevent early deaths
In other words just three percent of people who tested positive had been fully vaccinated, compared to 15 percent of people who tested negative.
That suggests (but doesn't prove) that fully vaccinated people are five times less at-risk of getting COVID-19, and translates to a vaccine effectiveness of 96 percent.
© Provided by Daily Mail However, the study did not include people who tested positive for coronavirus but never showed any symptoms, so it can't prove that the shot prevents infection.
Another 64 of the people who tested positive had had a first dose of either Pfizer or Moderna's vaccines, as had 241 people who tested negative.
Altogether, this means that even a single dose was 82 percent effective against preventing symptomatic COVID-19.
People who tested negative were twice as likely to have had a first dose compared to those who tested positive and had symptoms.
That's much better than what was found in Pfizer's own clinical trial, in which a single dose appeared to prevent just 52 percent of symptomatic illness.
© Provided by Daily Mail 
© Provided by Daily Mail However, UK data found that one shot prevented about 72 percent of illnesses 21 days later.
To-date, more than 36 percent of Americans have been fully vaccinated against COVID-19 and nearly 47 percent have had at least a first dose.
In other words, the risk of getting ill from COVID-19 has been reduced by 94 percent for more than 120 million people, and 155 million are at 82 percent less risk of getting sick.
Along with other studies, the new research was enough to convince the CDC that fully vaccinated people can go maskless and be at minimal risk of falling ill from COVID-19.
Read more